1. Striking leflunomide efficacy against refractory cutaneous sarcoidosis
Gérôme Bohelay, MD, Jean-David Bouaziz, MD, PhD, Hilario Nunes, MD, PhD, Michel Rybojad, MD, Martine Bagot, MD, PhD, Antoine Petit, MD, Liliane Laroche, MD, PhD 
Journal of the American Academy of Dermatology 
Volume 70, Issue 5, Pages e111-e113 (May 2014)
DOI: /j.jaad
Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions

2. Fig 1
A, Sarcoidosis skin lesions on the right cheek in patient 1 before leflunomide treatment. B, Complete remission in patient 1 after 12 months of leflunomide treatment.
Journal of the American Academy of Dermatology  , e111-e113DOI: ( /j.jaad )
Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions

3. Fig 2
A, Severe facial lupus pernio in patient 2 before combined leflunomide and methotrexate treatment. B, Rapid partial response of the facial lupus pernio in patient 2 after 4 months of combined leflunomide and methotrexate treatment.
Journal of the American Academy of Dermatology  , e111-e113DOI: ( /j.jaad )
Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions